Anti-Mullerian Hormone: A Marker of Ovarian Reserve and Its Association with Polycystic Ovarian Syndrome

Overview

Journal J Clin Diagn Res

Specialty General Medicine

Date 2017 Feb 18

PMID 28208941

Citations 6

Authors

Anil Kumar Verma

Sarita Rajbhar

Jyoti Mishra

Mayank Gupta

Mratunjai Sharma

Geeta Deshmukh

Wahid Ali

Affiliations

Soon will be listed here.

Abstract

Introduction: Anti-Mullerian Hormone (AMH) is a useful endocrine marker for assessing the ovarian reserve. AMH serum level reflects the number of follicles that have made the transition from the primordial pool into the growing follicle pool, and it is not controlled by gonadotropins.

Aim: The present study was conducted to correlate serum AMH levels with Polycystic Ovarian Syndrome (PCOS) and type of treatment protocol.

Materials And Methods: Serum AMH levels were performed in the early follicular phase (on 2 day of menstrual cycle) both in infertile females including PCOS and control women. The results were analyzed in relation to age, Body Mass Index (BMI), ovarian volume, serum Follicle Stimulating Hormone (FSH) levels, Antral Follicle Count (AFC), type of treatment protocols and also in association with PCOS patients. The serum levels of AMH were measured in all the participants on 2 day of menstrual cycle using ultra sensitive Enzyme Linked Immunosorbent Assay (ELISA).

Results: The plasma AMH levels were significantly higher in women with polycystic ovarian syndrome. The significant association was seen between FSH and AFC with AMH. However, no significant association was observed between AMH levels with age, BMI, ovarian volume and type of treatment protocols.

Conclusion: The serum AMH measurement was significantly higher in PCOS patients. No association with type of treatment protocol was obtained.

Citing Articles

Prenatal Silicon Dioxide Nanoparticles Exposure Reduces Female Offspring Fertility Without Affecting Males.

Lei M, Zhu Z, Wei C, Xie H, Guo R, Zhao Y Adv Sci (Weinh). 2024; 12(3):e2410353.

PMID: 39574356 PMC: 11744561. DOI: 10.1002/advs.202410353.

Comparative analysis of the bioaccumulation of bisphenol A in the blood serum and follicular fluid of women living in two areas with different environmental impacts.

Raimondo S, Chiusano M, Gentile M, Gentile T, Cuomo F, Gentile R Front Endocrinol (Lausanne). 2024; 15:1392550.

PMID: 39439569 PMC: 11495266. DOI: 10.3389/fendo.2024.1392550.

Anti-Müllerian Hormone Levels among Female Firefighters.

Davidson S, Jahnke S, Jung A, Burgess J, Jacobs E, Billheimer D Int J Environ Res Public Health. 2022; 19(10).

PMID: 35627519 PMC: 9141260. DOI: 10.3390/ijerph19105981.

Evaluation of Ovarian Reserve in Women With Rheumatoid Arthritis.

Pena-Lizola S, Sordia-Hernandez L, Garcia-Luna S, Valdes-Martinez O, Skinner-Taylor C, Garza-Elizondo M J Family Reprod Health. 2022; 15(4):236-241.

PMID: 35340801 PMC: 8897821. DOI: 10.18502/jfrh.v15i4.7889.

After cyclophosphamide exposure, granulosa cells recover their anti-müllerian hormone-producing ability but not their numbers.

Kim J, You S Cytometry A. 2020; 99(8):807-813.

PMID: 33342073 PMC: 8451832. DOI: 10.1002/cyto.a.24297.

References

Franks S . Polycystic ovary syndrome. N Engl J Med. 1995; 333(13):853-61. DOI: 10.1056/NEJM199509283331307. View

Raeissi A, Torki A, Moradi A, Mousavipoor S, Pirani M . Age-specific serum anti-mullerian hormone and follicle stimulating hormone concentrations in infertile Iranian women. Int J Fertil Steril. 2015; 9(1):27-32. PMC: 4410034. DOI: 10.22074/ijfs.2015.4205. View

Broekmans F, Soules M, Fauser B . Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009; 30(5):465-93. DOI: 10.1210/er.2009-0006. View

Karkanaki A, Vosnakis C, Panidis D . The clinical significance of anti-Müllerian hormone evaluation in gynecological endocrinology. Hormones (Athens). 2011; 10(2):95-103. DOI: 10.14310/horm.2002.1299. View

Parco S, Novelli C, Vascotto F, Princi T . Serum anti-Müllerian hormone as a predictive marker of polycystic ovarian syndrome. Int J Gen Med. 2011; 4:759-63. PMC: 3219763. DOI: 10.2147/IJGM.S25639. View

Buyuk E, Seifer D, Illions E, Grazi R, Lieman H . Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve. Fertil Steril. 2011; 95(7):2364-8. DOI: 10.1016/j.fertnstert.2011.03.081. View

Dumont A, Robin G, Catteau-Jonard S, Dewailly D . Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review. Reprod Biol Endocrinol. 2015; 13:137. PMC: 4687350. DOI: 10.1186/s12958-015-0134-9. View

Kunt C, Ozaksit G, Kurt R, Cakir Gungor A, Kanat-Pektas M, Kilic S . Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization. Arch Gynecol Obstet. 2011; 283(6):1415-21. DOI: 10.1007/s00404-011-1889-7. View

Lie Fong S, Visser J, Welt C, de Rijke Y, Eijkemans M, Broekmans F . Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab. 2012; 97(12):4650-5. PMC: 3683801. DOI: 10.1210/jc.2012-1440. View

10.

Fanchin R, Schonauer L, Righini C, Guibourdenche J, Frydman R, Taieb J . Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod. 2003; 18(2):323-7. DOI: 10.1093/humrep/deg042. View

11.

Visser J, Schipper I, Laven J, Themmen A . Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol. 2012; 8(6):331-41. DOI: 10.1038/nrendo.2011.224. View

12.

Cook-Andersen H, Chuan S, Maas K, Rosencrantz M, Su H, Lawson M . Lack of Serum anti-Mullerian hormone responses after recombinant human chorionic gonadotropin stimulation in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2014; 100(1):251-7. PMC: 4283023. DOI: 10.1210/jc.2014-2948. View

13.

Nardo L, Gelbaya T, Wilkinson H, Roberts S, Yates A, Pemberton P . Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril. 2008; 92(5):1586-93. DOI: 10.1016/j.fertnstert.2008.08.127. View

14.

Zadehmodarres S, Heidar Z, Razzaghi Z, Ebrahimi L, Soltanzadeh K, Abed F . Anti-mullerian hormon level and polycystic ovarian syndrome diagnosis. Iran J Reprod Med. 2015; 13(4):227-30. PMC: 4475772. View

15.

Saikumar P, Selvi V, Prabhu K, Venkatesh P, Krishna P . Anti mullerian hormone: a potential marker for recruited non growing follicle of ovarian pool in women with polycystic ovarian syndrome. J Clin Diagn Res. 2013; 7(9):1866-9. PMC: 3809623. DOI: 10.7860/JCDR/2013/5530.3337. View

16.

Singh A, Singh R . Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress. Indian J Endocrinol Metab. 2015; 19(6):731-43. PMC: 4673800. DOI: 10.4103/2230-8210.167548. View

17.

. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2003; 19(1):41-7. DOI: 10.1093/humrep/deh098. View